Two Targets, One Mission: Advancing Cancer Care With Bispecific Antibodies

Available until 3/12/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

Despite compelling evidence supporting the efficacy of bispecific antibodies in relapsed/refractory cancers, clinical adoption is hindered by knowledge gaps in mitigating and managing toxicities.

Upgrading Physical Assessment Tools

Available until 3/18/2026
Quick registration
1.0 contact hour available
Posted by ARNPs United of Washington State on 7/19/2024

Bob reviews new clinical equipment.

Smart Bombs in Cancer Care: Unlocking the Potential of Antibody-Drug Conjugates

Available until 3/19/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

This practical guide will help bridge some of these gaps by providing key insights into the complex landscape of ADCs, including their mechanisms of action, clinical applications, and limitations.

Biosimilars Explained: An Indispensable Tool for Modern Oncology Practice

Available until 3/26/2026
0.5 CME credits available (0.5 pharmacology)
Posted by i3Health on 6/10/2025

This monograph provides a comprehensive overview of biosimilars in oncology, addressing key barriers to adoption and offering practical guidance for their implementation in clinical practice.

ON DEMAND - A Deep Dive into Implicit Bias

Available until 3/28/2026
Quick registration
1.0 contact hour available
Posted by Illinois Society for Advanced Practice Nursing on 4/4/2024

A Deep Dive into Implicit Bias

Arterial Blood Flow Evaluation in the Lower Extremities

Available until 4/15/2026
Quick registration
1.0 contact hour available
Posted by ARNPs United of Washington State on 7/19/2024

Explore the use of in-office ultrasound to evaluate arterial blood flow in the lower extremities

Management of Venous Thromboembolism in Ambulatory Patients With Cancer

Available until 4/20/2026
1.0 contact hour available
Posted by i3Health on 6/10/2025

This activity will discuss strategies for early identification of patients receiving outpatient (ambulatory) chemotherapy who are at high risk for VTE.

Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes - Module 2

Available until 4/28/2026
1.0 CME credit available
Posted by i3Health on 6/4/2025

Expert faculty will explore strategies for enhancing patient care and keeping pace with advancements in melanoma.

Podcast: Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes - Module 2

Available until 4/28/2026
1.0 CME credit available
Posted by i3Health on 6/4/2025

Expert faculty will explore strategies for enhancing patient care and keeping pace with advancements in melanoma.

Podcast: Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes - Module 1

Available until 4/28/2026
1.0 CME credit available
Posted by i3Health on 6/4/2025

Expert faculty will explore how to optimize treatment strategies in melanoma.